BNTX - BioNTech SE

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts881413
Avg. Estimate-0.321.095.223.49
Low estimate-2.68-0.533.630.35
High estimate1.862.236.746.1
Year ago EPS6.367.4440.525.22
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts771413
Avg. Estimate982.44M1.4B5.8B5.06B
Low estimate339.04M964.99M5.26B3.63B
High estimate1.64B1.89B7.08B6.92B
Year ago sales3.26B2.21B18.57B5.8B
Sales growth (year/est)-69.80%-37.00%-68.80%-12.70%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS6.994.88.570.15
Actual EPS6.367.449.942.2
Difference-0.632.641.372.05
Surprise %-9.00%55.00%16.00%1,366.70%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate-0.321.095.223.49
7 days ago-0.941.035.324.7
30 days ago0.162.677.935.55
60 days ago0.642.49.576.23
90 days ago1.693.614.678.87
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 days22N/AN/A
Up last 30 days5383
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A11
Growth estimatesBNTXIndustrySector(s)S&P 500
Current qtr.-105.00%N/AN/AN/A
Next qtr.-85.30%N/AN/AN/A
Current year-87.10%N/AN/AN/A
Next year-33.10%N/AN/AN/A
Next 5 years (per annum)-57.25%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A